Guided Therapeutics (GTHP) Change in Account Payables (2011 - 2021)
Guided Therapeutics (GTHP) posted Change in Account Payables of -$84000.0 for Q2 2021, down 389.66% sequentially from $29000.0 in Q1 2021, and down 197.67% YoY from $86000.0 in Q2 2020.
Guided Therapeutics (GTHP) Change in Account Payables (2011 - 2021) Analysis & Trends
Guided Therapeutics has reported Change in Account Payables for 11 years, with the latest figure at -$84000.0 in Q2 2021.
- Quarterly Change in Account Payables fell 197.67% year-over-year to -$84000.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was -$446000.0 (down 4560.0% YoY) and the FY2020 annual result came in at -$372000.0, down 1960.0% from the prior year.
- Change in Account Payables fell to -$84000.0 in Q2 2021 per GTHP's latest filing, from $29000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $148000.0 in Q1 2017 and troughed at -$208000.0 in Q3 2020.
- A 5-year average of $388.89 and a median of $18500.0 in 2018 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2019 and 2020: Change in Account Payables soared 353.33% in 2019, then tumbled 730.3% in 2020.
- Over 5 years, Change in Account Payables stood at $54000.0 in 2017, then plunged by 85.19% to $8000.0 in 2018, then sank by 625.0% to -$42000.0 in 2019, then sank by 335.71% to -$183000.0 in 2020, then soared by 54.1% to -$84000.0 in 2021.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$84000.0, $29000.0, and -$183000.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -84,000.00 |
| Jun 30, 2021 | -84,000.00 |
| Mar 31, 2021 | 29,000.00 |
| Mar 31, 2021 | 29,000.00 |
| Dec 31, 2020 | -183,000.00 |
| Dec 31, 2020 | -183,000.00 |
| Sep 30, 2020 | -208,000.00 |
| Sep 30, 2020 | -208,000.00 |
| Jun 30, 2020 | 86,000.00 |
| Jun 30, 2020 | 86,000.00 |
| Mar 31, 2020 | -67,000.00 |
| Mar 31, 2020 | -67,000.00 |
| Dec 31, 2019 | -42,000.00 |
| Dec 31, 2019 | -42,000.00 |
| Sep 30, 2019 | 33,000.00 |
| Sep 30, 2019 | 33,000.00 |
| Jun 30, 2019 | 38,000.00 |
| Jun 30, 2019 | 38,000.00 |
| Mar 31, 2019 | -9,000.00 |
| Mar 31, 2019 | -9,000.00 |